Skip to main content
OpenTrials

Clinical trial condition

Human Parainfluenza Virus Type 3

Explore clinical trials studying Human Parainfluenza Virus Type 3. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Human Parainfluenza Virus Type 3 trial results

Completed

Study of the Infectivity, Safety and Immunogenicity of Two Recombinant, Live-Attenuated, B/HPIV3 Vectored Vaccines Expressing the Fusion Glycoprotein of HMPV Delivered by Nasal Spray to HPIV3-Seropositive Children 24 to <60 Months of Age

NCT06546423

Conditions
Human Metapneumovirus, Human Parainfluenza Virus Type 3
Locations
  • CIR - Rangos, Johns Hopkins Bloomberg School of Public Health Baltimore, Maryland, United States
  • CIR South Columbia, Maryland, United States
  • University of Rochester Medical Center Rochester, New York, United States
  • Vanderbilt University Medical Center Nashville, Tennessee, United States
View Trial Details

Related conditions